Magnesium sulfate paste

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)

العنصر النشط:

Magnesium sulfate dried; Glycerol; Phenol

متاح من:

A A H Pharmaceuticals Ltd

ATC رمز:

D11AX05

INN (الاسم الدولي):

Magnesium sulfate dried; Glycerol; Phenol

جرعة:

450mg/1gram ; 550mg/1gram ; 5mg/1gram

الشكل الصيدلاني:

Cutaneous paste

طريقة التعاطي:

Cutaneous

الفئة:

No Controlled Drug Status

نوع الوصفة الطبية :

Valid as a prescribable product

ملخص المنتج:

BNF: 13100500

نشرة المعلومات

PCP HEADER BOX
APPROVED BY DATE
OPERATOR
ARTWORK NO
CRN
FIX
REASON F
SUF
OR
CHANGE
ISSUED BY
DATE
MHRA/IMB
SUBMISSION
REQUIRED
Yes
A
gill.kennedy
632344
12729
Change spelling of "sulphate" to
"sulfate" at request of licence
holder.
MHRA HEADER BOX
PRODUCT TITLE
C
FONTS USED
OLOURS USED
COMPONENT
PACK SIZE
IG CODE
DIMENSIONS
PROOF NO.
DATE
Landscape peelable label
50g
21566809
35mm x 110mm
2
10.02.2016
Process Cyan
Process Magenta
Process Yellow
Process Black
Keyline (non-printing)
Braille
Text free area (non-printing)
Magnesium Sulfate Paste BP
Helvetica
OCRB
Print free area (non-printing)
FRONT PLY
FRONT REVERSE PLY
BOTTOM PLY
MAGNESIUM
SULFATE
PASTE BP
(MAGNESIUM
SULFATE, PHENOL)
A DRAWING PASTE TO HELP
TREAT MINOR SKIN
INFECTIONS, INCLUDING BOILS
AND REDUCE SWELLING
READ ALL THE LEAFLET BEFORE
USE. PEEL WHERE SHOWN.
Stir paste well before use.
Apply it to the skin.
ADULTS, ELDERLY AND CHILDREN:
Apply liberally to the affected area
and cover with a clean dressing.
Do not use repeatedly.
If symptoms persist talk to your
doctor.
FOR EXTERNAL USE ONLY.
PEEL WHERE SHOWN FOR
PRECAUTIONS.
ACTIVE INGREDIENTS: Dried
Magnesium Sulfate 47.76%
w/w, Phenol 0.49% w/w.
ALSO CONTAINS: glycerol (E422).
MA holder and manufacturer:
KL Pharmaceutical Ltd.,
Irvine, Ayrshire KA11 4HP.
Distributor: Thornton &
Ross Ltd., Huddersfield,
HD7 5QH, UK.
Do not store above 25˚C.
KEEP OUT OF THE SIGHT
AND REACH OF CHILDREN.
PL 03436/0002
21566809
The ingredients in Magnesium Sulfate Paste help to draw
puss from minor skin infections including boils and so reduce
swelling.
1. BEFORE YOU USE THIS MEDICINE
DO NOT USE THE MEDICINE IF YOU HAVE….
• An ALLERGY to any of the ingredients listed on the front.
PREGNANT OR BREASTFEEDING….
Ask your doctor or pharmacist for advice before using this
medicine if you are pregnant, might be pregnant or are
breastfeeding.
2. POSSIBLE SIDE EFFECTS
There are no known side effects from using this medicine as
directed.
If you notice any side effects, stop use and tell your doctor or
pharmacist. They will te

خصائص المنتج

1.
TRADE NAME OF THE MEDICINAL PRODUCT
Magnesium Sulfate Paste BP
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Name of ingredient
Quantity
Dried Magnesium Sulfate
47. 762g
Phenol
0.497g
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Paste.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
As an adjunct to the management of superficial skin infections,
including boils.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults, elderly and children
Apply to the affected area as required. There is no difference in the
quantity required for
affected areas or for children, adults or the elderly.
Stir well before use and apply liberally to the affected area.
Cover with a dressing.
Method of Administration
For topical application
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
For external use only.
Do not use repeatedly.
4.5.
INTERACTIONS WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION
No significant clinical interactions known.
4.6
FERTILITY, PREGNANCY AND LACTATION
As with all medicines it may be used during this period if the
benefits outweigh the risks.
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Not applicable.
4.8
UNDESIRABLE EFFECTS
None known
REPORTING OF SUSPECTED ADVERSE REACTIONS
Reporting suspected adverse reactions after authorisation of the
medicinal product is
important. It allows continued monitoring of the benefit/risk balance
of the medicinal product.
Healthcare professionals are asked to report any suspected adverse
reactions via the Yellow
Card Scheme at: www.mhra.gov.uk/yellowcard
4.9.
OVERDOSE
Should accidental ingestion occur, treat symptomatically.
5
PHARMACOLOGICAL PROPERTIES
5.1
PHARMACODYNAMIC PROPERTIES
Pharmacotherapeutic Group: Other Dermatologicals, Magnesium Sulfate
ATC code: D11A X05
Topical application of the ingredients of the paste help to draw
infected wounds and
reduce inflammation.
5.2.
PHARMACOKINETIC PROPERTIES
Not applicable.
5.3.
PRE